ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 82.00

Change

0.00 (0.00)%

Market Cap

USD 1.31B

Volume

0.13M

Avg Analyst Target

USD 115.00 (+40.24%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of March 9, 2021, the company served consumers through 212 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas. Address: 6303 Cowboys Way, Frisco, TX, United States, 75034

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys Inc

N/A

USD5.53B 22.74 14.19
ACHC Acadia Healthcare Company Inc

N/A

USD5.19B 47.80 14.79
LHCG LHC Group Inc

N/A

USD4.61B 39.03 19.55
ENSG The Ensign Group Inc

N/A

USD3.98B 21.67 16.97
SGRY Surgery Partners Inc

N/A

USD3.59B 63.00 18.05
AMEH Apollo Medical Holdings Inc

N/A

USD3.20B 56.41 15.74
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
CMPS COMPASS Pathways plc

N/A

USD1.62B N/A N/A
HCSG Healthcare Services Group Inc

N/A

USD1.50B 21.21 14.00
AVAH Aveanna Healthcare Holdings In..

N/A

USD1.33B N/A 10.66

ETFs Containing ADUS

Symbol Name Weight Mer Price(Change) Market Cap

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.97% 29% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.97% 29% F 17% F
Trailing 12 Months  
Capital Gain -18.94% 29% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.94% 29% F 16% F
Trailing 5 Years  
Capital Gain 211.91% 54% F 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 211.91% 54% F 83% B
Average Annual (5 Year Horizon)  
Capital Gain 33.56% 57% F 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.56% 57% F 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 32.29% 81% B- 56% F
Risk Adjusted Return 103.94% 86% B 94% A
Market Capitalization 1.31B 61% D- 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 34.45 50% F 29% F
Price/Book Ratio 2.25 74% C 56% F
Price / Cash Flow Ratio 108.59 4% F 4% F
EV/EBITDA 19.76 28% F 37% F
Management Effectiveness  
Return on Equity 7.33% 59% F 63% D
Return on Invested Capital 4.54% 39% F 64% D
Return on Assets 6.23% 74% C 84% B
Debt to Equity Ratio 40.77% 37% F 43% F
Technical Ratios  
Short Ratio 4.92 39% F 30% F
Short Percent 2.79% 61% D- 51% F
Beta 0.77 60% D- 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.